RALEIGH, N.C., Nov. 9 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will participate in the 2009 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition to be held on 9 -12 November at the Los Angeles Convention Center in Los Angeles, CA, USA. PRA will be exhibiting at booth number 2519 and leadership from its Bioanalytical Laboratory and Phase I Clinic will be in attendance. Leading PRA's delegation will be Peter Ketelaar, MSc, Vice President of Laboratory Services. At PRA, Mr. Ketelaar is responsible for ensuring high-quality study execution for PRA's Bioanalytical Laboratory.

Berend Oosterhuis, PhD, Scientific Director for Early Development Services in the Netherlands, will present a poster on GMP for Early Exploratory Clinical Studies. During his presentation, he will reflect on the reasons why early clinical studies do not work without flexible, on-site, small-scale, GMP manufacturing. At PRA, Dr. Oosterhuis acts as an internal and external consultant for issues concerning drug development and regulatory affairs. He is a trained pharmacist and has authored or co-authored more than 85 scientific publications in the fields of bioanalysis, pharmacokinetics and clinical pharmacology in peer-reviewed scientific journals. In support of drug registration, he is the author of expert opinions and expert reports.

PRA's Early Development Services group provides a full range of Phase I-IIa services with 228 beds in the United States, the Netherlands and the Czech Republic. PRA's GLP-compliant Bioanalytical Laboratory in the Netherlands has been providing a comprehensive range of services to pharma and biotech clients for nearly 25 years.

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in oncology, neurosciences, respiratory/allergy, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials through its 36+ global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International